Brefonalol

Brefonalol
Names
	IUPAC name 6-[1-Hydroxy-2-[(2-methyl-4-phenylbutan-2-yl)amino]ethyl]-3,4-dihydro-1H-quinolin-2-one
	Other names Brefanolol
Identifiers
CAS Number	104051-20-9 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL1742432;
ChemSpider	59289;
PubChem CID	65880;
UNII	DVO6SSG9S3 ;
CompTox Dashboard (EPA)	DTXSID20869414 ;
	InChI InChI=1S/C22H28N2O2/c1-22(2,13-12-16-6-4-3-5-7-16)23-15-20(25)18-8-10-19-17(14-18)9-11-21(26)24-19/h3-8,10,14,20,23,25H,9,11-13,15H2,1-2H3,(H,24,26) Key: YYUZPBGIBVJYSI-UHFFFAOYSA-N; InChI=1/C22H28N2O2/c1-22(2,13-12-16-6-4-3-5-7-16)23-15-20(25)18-8-10-19-17(14-18)9-11-21(26)24-19/h3-8,10,14,20,23,25H,9,11-13,15H2,1-2H3,(H,24,26) Key: YYUZPBGIBVJYSI-UHFFFAOYAN;
	SMILES CC(C)(CCC1=CC=CC=C1)NCC(C2=CC3=C(C=C2)NC(=O)CC3)O;
Properties
Chemical formula	C22H28N2O2
Molar mass	352.478 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Brefonalol is a beta-adrenergic antagonist that reduces heart frequency and blood pressure and dilates blood vessels. It has been studied in around 1990,^[1] but is not known to be marketed as of 2021^[update].

References

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.